Shows
The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesTranslational Drug Development in AD: Promising Strategies for Treatment and Disease Modification, AD/PD™ Session SpotlightIn this episode, we unpack the key insights from Forum Discussion 04 at the AD/PD™ 2025 International Conference — “Translational Drug Development in AD (Phase I–III) and Relevance for Treatment and Disease Modification: What Could Be Promising Strategies? Small Molecules for Symptomatic & Disease Modification.”Moderated by Dr. Jeffrey Cummings (USA) and Dr. Howard Fillit (USA), this forward-looking discussion brought together leaders in drug development and clinical research, including Prof. Miia Kivipelto (Sweden), Dr. Reisa Sperling (USA), Prof. Philip Scheltens (Netherlands), and Dr. Geoffrey Kerchner (Switzerland), to explore promising approaches in Alzheimer’s treatment — from lifestyle interventions...2025-07-3124 min
ATTD: Advanced Technologies and Treatments for DiabetesInitiating, Titrating, and Monitoring Long-Acting InsulinIn today’s episode, host Ginger Vieria is joined by Aimée José, RD, CDCES to discuss factors for consideration when initiating, titrating, and monitoring long-acting insulin.Their conversation provides you with step-by-step guidance on dose titration and adjustments, monitoring and managing adverse effects, and strategies for patient education and engagement during initiation. Aimée draws from her clinical experience working with patients in a non-judgemental manner, encouraging better collaboration between patient and provider.Aimée José is Principal Clinical Educator at Codex Health. She’s a highly skilled Diabetes Educator with expertise in clinical diabetes...2025-07-2938 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesTreatment of DLB and PDD: Status and New Developments, AD/PD™ Session SpotlightIn this episode, we feature Plenary Lecture 04 from the AD/PD™ 2025 International Conference — the Eric N. Birch Memorial Lecture, titled “Treatment of DLB and PDD: Status and New Developments.”Chaired by Dr. Sandra Moose (USA) and presented by Prof. Dag Aarsland (UK), this important plenary cast a spotlight on two often-overlooked conditions in the neurodegenerative disease landscape: Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD).Prof. Aarsland delivered a comprehensive update on the therapeutic landscape of Lewy body dementia, both current standards and promising directions in the pipeli...2025-07-2421 min
ATTD: Advanced Technologies and Treatments for DiabetesPatient Selection Criteria for Long-Acting Insulin TherapyIn today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.They explore factors including insulin resistance, lifestyle considerations, and treatment goals, and draw from real-world examples of how clinicians decide on the best candidates for long-acting insulin therapy.Ladan Davallow, MD is a Pediatric Endocrinologist and Childhood Type 1 Diabetes Consultant & Certified Coach.She is based in the Medical University of South Carolina Children’s Health Hospital, and is the Co-Founder of and Pediatric Endocrinologist at EndoMD Health, a Virtual Pediatric Endocrine Care...2025-07-2238 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesImproving the Therapeutic Potential of Immunotherapies in Alzheimer’s Disease, AD/PD™ Session SpotlightIn this episode, we spotlight Forum Discussion 03 from the AD/PD™ 2025 International Conference: “Improving the Therapeutic Potential of Immunotherapies in AD – Can Novel Strategies or Next Generation Drugs Halt or Further Delay Disease Progression?”Chaired by Dr. Rudolph Tanzi (USA) and Dr. Suzanne Hendrix (USA), this thought-provoking panel brought together leaders in Alzheimer’s disease research and development: Dr. Chad Swanson, Dr. Donna Wilcock, Dr. Yuval Zabar, Dr. Janice Smith, and Dr. Eric Siemers.The discussion centered on how the next generation of Alzheimer’s immunotherapies can go beyond current anti...2025-07-1017 min
ATTD: Advanced Technologies and Treatments for DiabetesUnderstanding the Benefits of Long-Acting InsulinIn today’s episode Ginger Vieria is joined by Diana Isaacs, PharmD, and Endocrine Clinical Pharmacist, to dive deeper into the pharmacokinetics and pharmacodynamics of long-acting insulin.They explore how long-acting insulin can improve blood glucose levels, reduce the burden of daily injections, and simplify insulin management for the person with diabetes.Diana Isaacs is a diabetes advocate and speaker. She’s a Director in Education & Training in Diabetes Technology at the Cleveland Clinic, and she’s also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinic...2025-07-0829 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesGLP-1R Agonist Effects in the Brain: Exploring Semaglutide and Neuroinflammation, AD/PD™ Session SpotlightIn this episode, we explore Plenary Lecture 2 from the AD/PD™ 2025 International Conference: “GLP-1R Agonist Effects in Brain.”Moderated by Dr. Cynthia Lemere (USA) and Dr. Henrietta Nielsen (Sweden), this featured lecture was presented by Dr. Lotte Bjerre Knudsen (Denmark), Chief Scientific Advisor at Novo Nordisk. A pioneering force in GLP-1 drug development and co-inventor of liraglutide, Dr. Knudsen shared novel data on semaglutide’s potential neuroprotective mechanisms, as the drug advances through Phase 3 trials (EVOKE & EVOKE+) for Alzheimer’s disease.Key highlights include:• GLP-1’s dual role as a...2025-07-0323 min
ATTD: Advanced Technologies and Treatments for DiabetesIntroduction to Long-Acting Insulin TherapyIn the first episode of ATTD’s brand new series on long-acting insulin, join our host Ginger Vieira and guest Jennifer Okemah, RD, CDCES, as they provide an overview of the role of long-acting insulin in diabetes management, the potential benefits, and the evolution of the different formulations available today.Jennifer Okemah has been a Registered Dietitian (RD)/Nutritionist since 2005 and a Certified Diabetes Care and Education Specialist (CDCES) since 2007.She has an additional certification as a Sports Specialist in Dietetics as well as being Board Certified in Advanced Diabetes Management.Explore more on...2025-06-2434 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesIntegrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and AI in MCI & AD, AD/PD™ Session SpotlightIn this episode, we dive into one of the most forward-looking conversations from the AD/PD™ 2025 International Conference — Forum Discussion 2, "Integrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and AI in MCI & AD."Moderated by Dr. Oskar Hansson (Sweden) and Dr. Melissa Murray (USA), this dynamic session was led by Dr. Rhoda Au (USA), Prof. Charlotte Teunissen (Netherlands), Dr. Danielle Graham (USA), Dr. Bryan Cobb (USA) and Dr. Tobias Bittner (Switzerland). The discussion explored how emerging biomarkers — from blood-based diagnostics to digital tools powered by AI — are reshaping how we detect and monitor Alzheime...2025-06-1920 min
ATTD: Advanced Technologies and Treatments for DiabetesIntroducing ATTD Diabetes Talks: Long-Acting Insulin UncoveredWhat’s next in long-acting insulin therapy? Find out in ATTD Diabetes Talks: Long-Acting Insulin Uncovered, a new podcast for healthcare professionals who want to stay ahead in diabetes care.Hosted by Ginger Vieira and powered by ATTD, this series brings you real conversations with CDCESs, PharmDs, pediatric endocrinologists, and people living with diabetes.We’ll dive into the latest trends, explore clinical benefits, discuss patient selection strategies, and share real-world success stories to help you apply new insights in your practice.Subscribe now and join us as we uncover how long-acting insulin is s...2025-06-1802 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesThe Alzheimer's Disease Drug Development Pipeline: Observations and Implications, AD/PD™ Session SpotlightIn this episode of AD/PD™ Session Spotlight, we present Plenary Lecture 1 from AD/PD™ 2025, titled "The Alzheimer's Disease Drug Development Pipeline: Observations and Implications," delivered by Dr. Jeffrey Cummings (USA) and chaired by Dr. Cynthia Lemere (USA) and Dr. Henrietta Nielsen (Sweden).Renowned for his leadership in Alzheimer’s research, Dr. Cummings offers a sweeping and data-driven overview of the evolving landscape of Alzheimer’s drug development—spotlighting trends, challenges, and opportunities shaping the future of treatment.Key highlights include:• A record 182 active trials involving 138 unique drug candidates...2025-06-0515 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesPlasma Biomarkers for Dementias in the Era of Disease-Modifying Therapies, AD/PD™ Session SpotlightIn episode 2 of AD/PD™ Session Spotlight, we feature Plenary Lecture 3, the Don Price Memorial Lecture, titled "Plasma Biomarkers for Dementias in the Era of Disease-Modifying Therapies," presented by Prof. Charlotte Teunissen (The Netherlands) and chaired by Dr. Sangram Sisodia (USA).This compelling lecture honors the legacy of Dr. Donald L. Price and explores the transformative role of plasma biomarkers in Alzheimer’s disease care, from diagnosis to personalized treatment strategies.Key highlights include:• The clinical readiness of plasma biomarkers like P-tau217 for diagnosing and monitoring Alzheimer’s diseas...2025-05-2217 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesVarying Regulatory Philosophies and AD Approval Priorities, AD/PD™ Session SpotlightIn this episode of AD/PD™ Session Spotlight, we delve into Forum Discussion 1, "Varying Regulatory Philosophies and AD Approval Priorities – USA, EU, Asia, and Other Parts of the World," a dynamic exchange exploring how regional regulatory approaches impact the development, approval, and accessibility of Alzheimer’s disease therapies.Co-moderated by Agneta Nordberg (Sweden) and David Holtzman (USA), this discussion brings together insights from international regulatory and clinical experts: Naohiro Egawa (Japan), Tamara Shiner (Israel), Henrik Zetterberg (Sweden), and Pavel Balabanov (The Netherlands).Key highlights include:• The complex landscap...2025-05-1418 minThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative DiseasesWelcome to the AD/PD™ Session SpotlightWelcome to AD/PD™ Session Spotlight, an official podcast series by AD/PD™. The podcast will discuss the latest cutting-edge science and real-world clinical impact in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases, presented at the AD/PD™ 2025 Conference.This AI-generated series is built for medical professionals and researchers who want to stay current with the latest breakthroughs without missing a step. Each episode offers concise, curated summaries of key sessions from the AD/PD™ 2025 Conference in Vienna. From novel therapies and biomarker discovery to translational research and trial data, we’ll spotlight the science th...2025-04-1701 min
ATTD: Advanced Technologies and Treatments for DiabetesToward the Cure of Type 1 Diabetes, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.Join us as we summarize key takeaways from these thought-provoking presentations:Biomaterials to Aid Beta Cell Replacement - Current and Future Perspectives – Dr. Victoria SalemNew Strategies for Curative Therapies for Diabetes – Prof. Stefan BornsteinUpdate on Efforts to Interdict Type 1 Diabetes – Dr. Desmond SchatzThis episode is an essential listen for endocrinologists, diabet...2025-03-2228 min
ATTD: Advanced Technologies and Treatments for DiabetesTime in Tight Range: Primary Treatment Goal in Diabetes, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.Join us as we summarize key takeaways from these thought-provoking presentations:View – Dr. Anders CarlsonCounterview – Dr. Jeremy Pettus Rebuttal by Speaker Presenting View – Dr. Anders CarlsonRebuttal by Speaker Presenting Counterview – Dr. Jeremy Pettus2025-03-2220 min
ATTD: Advanced Technologies and Treatments for DiabetesDebate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and challenges of continuous ketone monitoring, exploring its role in preventing diabetic ketoacidosis and its place in diabetes management.Join us as we summarize key takeaways from these thought-provoking presentations:View – Prof. Jennifer SherrCounterview – Dr. Steven EdelmanRebuttal by Speaker Presenting View – Prof. Jennifer SherrRebuttal by Speaker Presenting Counterview – Dr. Steven EdelmanThis episode is an essential listen for endo...2025-03-2221 min
ATTD: Advanced Technologies and Treatments for DiabetesAI-Driven Healthcare: Opportunities and Challenges, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hypertension management, along with the challenges of integrating machine learning into clinical practice while ensuring patient safety and regulatory compliance.Join us as we summarize key takeaways from these thought-provoking presentations:Artificial Intelligence (AI) for Diabetes Treatment: A Next Step of Systematic Review and Network Meta-Analyses? – Prof. Oliver SchnellData-Driven Machine Learning: Unlocking the Future of Closed-Loop Diabetes Care – Prof. Yao QinMultiomics Biomarkers for Improved Diag...2025-03-2227 min
ATTD: Advanced Technologies and Treatments for DiabetesDebate: Adaptive Trials in the Post-Teplizumab Era, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Adaptive Trials in the Post-Teplizumab Era: To Placebo or Not to Placebo?, featuring a lively discussion on the ethics and necessity of placebo-controlled trials in type 1 diabetes research, with a focus on adaptive trial designs and the future of treatment testing.Join us as we summarize key takeaways from these thought-provoking presentations:Yes, We Should Continue with Placebo – Prof. Colin DayanNo, We Should Use Only Active (Approved) Control – Dr. Laura JacobsenRebuttal by Speaker Presenting the Case for 'Yes' – Prof. Colin...2025-03-2232 min
ATTD: Advanced Technologies and Treatments for DiabetesUpdates on Diabetes Management and Female Health, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Updates on Diabetes Management and Female Health, featuring discussions on gender-specific challenges in diabetes care, the role of technology and AI in addressing these disparities, and the need for personalized treatment approaches for women with diabetes.Join us as we summarize key takeaways from these thought-provoking presentations: Leveraging Technology to Address Gender Differences in Diabetes – Prof. Eda Cengiz The Role of Estradiol in Energy and Glucose-Insulin Homeostasis – Dr. Lia Bally Impact of Sex on the Control of Type 2 Diabetes – Prof. Chiara...2025-03-2229 min
ATTD: Advanced Technologies and Treatments for DiabetesType 2 Diabetes: Empowering Patients with Personalized Treatment, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Type 2 Diabetes: Empowering Patients with Personalized Treatment, featuring cutting-edge discussions on the role of SGLT2 inhibitors, CGM, and personalized approaches to managing type 2 diabetes and pre-diabetes, with a focus on improving patient outcomes.Join us as we summarize key takeaways from these thought-provoking presentations:SGLT2i Use in Young People Following Approval by FDA and EMA in Type 2 Diabetes – Dr. Lori LaffelDo Different Types of Prediabetes Require Different Types of Prevention Approaches? – Dr. Viswanathan MohanUse of CGM in Pre-Type 2 Diabetes – Prof...2025-03-2226 min
ATTD: Advanced Technologies and Treatments for DiabetesDecision Support Technologies – Are They Delivering?, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Decision Support Technologies – Are They Delivering?, featuring discussions on the effectiveness of AI-driven tools in improving diabetes management, enhancing patient autonomy, and supporting healthcare providers in delivering personalized care.Join us as we summarize key takeaways from these thought-provoking presentations:Decision Support Systems for Healthcare Providers and People with Diabetes – Prof. Revital NimriSpotlight-AQ: Harnessing AI to Deliver the First Step in the Precision Medicine Pathway – Prof. Katharine Barnard-KellyAI Bolus Calculator for People on Multiple Daily Injections – Prof. Anas El FathiCan Decision Support for Evaluating AID Uploads Assist C...2025-03-2229 min
ATTD: Advanced Technologies and Treatments for DiabetesFully Closed-Loop: A New Era of Control, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Fully Closed-Loop: A New Era of Control, featuring cutting-edge advancements in machine learning–driveninsulin delivery systems and their potential to transform diabetes management across everyday life, exercise, meals, and clinical settings.Join us as we summarize key takeaways from these thought-provoking presentations:Machine Learning– The Key to Fully Automated Closed-Loop – Prof. Boris KovatchevMeal Compositions and Postprandial Glycemic Management in FullyClosed-Loop Systems – Dr. Laya Ekhlaspour Fully Closed-Loop: From Announced to Unannounced Exercise – Prof.Othmar MoserPerioperative Closed-Loop Use During Major Surgery – Dr. Lia BallyThis episode is an essential...2025-03-2227 min
ATTD: Advanced Technologies and Treatments for DiabetesUse of Technology in Pregnancy, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Use of Technology in Pregnancy, featuring innovative discussions on the challenges of managing diabetes during pregnancy, the impact of hybrid closed-loop and insulin delivery systems on glycemic control, and the need for individualized care to optimize outcomes for both mothers and babies.Join us as we summarize key takeaways from these thought-provoking presentations:How Do You Know That Your Pregnant Woman with Diabetes is Well Controlled? – Prof. Yariv YogevUse of the Medtronic 780G Hybrid Closed-Loop System in Type 1 Diabetes Pregnancy – Prof. Katrien BenhalimaThe Role of CamAPS FX i...2025-03-2120 min
ATTD: Advanced Technologies and Treatments for DiabetesTime in Tight Glycemic Range: A Crucial Goal or Burden? ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Time in Tight Glycemic Range: A Crucial Goal or an Unnecessary Burden?, featuring an in-depth exploration of the complexities behind glycemic control, the challenges of achieving tight ranges, and the need for personalized, accessible diabetes management strategies. Join us as we summarize key takeaways from these thought-provoking presentations: Time in Tight Glycemic Range: Overview of the Physiological Data – Dr. Anders Carlson Qualitative Data Perspective – Dr. Molly Tanenbaum Health Inequalities Perspective – Dr. David Kerr PwD Perspective – Ms. Julie Heverly This episode is an essential listen for endocrinologis...2025-03-2119 min
ATTD: Advanced Technologies and Treatments for DiabetesClosed-Loop Control Systems: Advancements and Applications, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Closed-Loop Control Systems: Advancements and Applications, featuring breakthrough discussions on the latest closed-loop systems, their impact on glycemic control, and the ongoing advancements aimed at improving accessibility and outcomes for individuals with type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Closed-loop from Diagnosis: What Have We Learned from the Longest-Ever Closed-Loop Study - Dr. Charlotte Boughton NAP @ Home: First Outpatient Studies of Neural-net Artificial Pancreas -Dr. Laya Ekhlaspour Cam APS FX in Very Young Children in Italy; 2-Year Follow-Up - Prof. Marc...2025-03-2128 min
ATTD: Advanced Technologies and Treatments for DiabetesATTD Yearbook Session, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into the ATTD Yearbook Session, featuring a dynamic review of the year’s most impactful advances in diabetes technology, therapies, and care delivery—from AI-driven insulin systems to digital health, telemedicine, and emerging treatments across all ages and care settings. Join us as we summarize key takeaways from these thought-provoking presentations: Virtual Clinics for Diabetes Care – Prof. Satish Garg Continuous and Intermittent Glucose Monitoring in 2024 – Dr. Klemen Dovč Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan LalNew Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester Closed-Loop, Artificial Intelligence-Based Decis...2025-03-2130 min
ATTD: Advanced Technologies and Treatments for DiabetesPediatric Obesity: Challenges & Future Directions, ATTD 2025 Conference Catch-UpIn this episode of ATTD Conference Catch-Up, we dive into Pediatric Obesity: Current Challenges and Future Directions, featuring a comprehensive look at the genetic, environmental, and therapeutic factors shaping the future of pediatric obesity management.Join us as we summarize key takeaways from these thought-provoking presentations:A Holistic Approach to Understanding Childhood Obesity – Prof. Antje KörnerAdvances in Pharmacological Interventions for Pediatric and Adolescent Obesity – Current Status and Future Prospects – Dr. Jamie MatuTherapy for Monogenic Obesity – Prof. Primož KotnikThis episode is an essential listen for pediatric endocrinologists, obesity specialists, diabetes care teams, and health...2025-03-2122 min
ATTD: Advanced Technologies and Treatments for DiabetesArtificial Intelligence (AI) Technology for Diabetes, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Artificial Intelligence (AI) Technology for Diabetes, featuring explorations of AI's role in predicting complications, enhancing automated insulin delivery, and advancing personalized diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: Machine Learning Methods Predicting Diabetes Complications – Dr. Riccardo Bellazzi Applications of Generative AI to Diabetes – Prof. Josep Vehi AI-Enabled Meal Detection and Dosing in Automated Insulin Delivery Systems – Dr. Peter Jacobs AI Takes Diabetes Management Beyond AID – Dr. Deborah Wake This episode is an essential listen for endocrinologists, diabetes speci...2025-03-2024 min
ATTD: Advanced Technologies and Treatments for DiabetesContinuous Glucose Monitoring (CGM) in Type 2 Diabetes, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) in Type 2 Diabetes, featuring discussions on the impact of CGM on glycemic control, cost-effectiveness, and its integration with lifestyle interventions and medications for improved diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: Real World Data on CGM in Type 2 Diabetes - Glucose Control Improvement – Dr. Richard Bergenstal Glycemic Excursion Minimization (GEM): A Lifestyle Intervention for the Management of Type 2 Diabetes – Prof. Chiara Fabris Cost Benefits of CGM Use in Type 2 Diabetes – Dr. Roy Beck CGM-Based Intensification and De-Intensif...2025-03-2020 min
ATTD: Advanced Technologies and Treatments for DiabetesObesity and Type 1 Diabetes: Tailoring Treatment, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Obesity and Type 1 Diabetes: Tailoring Treatment, featuring insights on the prevalence, pharmacotherapy, and lifestyle strategies for managing obesity in individuals with Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Prevalence of Obesity in Type 1 Diabetes – Prof. Shlomit Shalitin Newer GLP Analogs for Treatment of Obesity in Type 1 Diabetes – Prof. Satish Garg Use of GLP1 Analogs in Youth with Type 1 Diabetes for Weight Management in Youth – Dr. Lori Laffel Changing Behaviors to Manage Weight in Children and Adolescents with Type 1 Diabetes – Dr. Carmel Smart ...2025-03-2029 min
ATTD: Advanced Technologies and Treatments for DiabetesDigital Twins and Artificial Intelligence, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Digital Twins and Artificial Intelligence, featuring cutting-edge applications of digital twins and AI to simulate patient-specific scenarios and optimize personalized treatment strategies in diabetes care. Join us as we summarize key takeaways from these thought-provoking presentations: Creating Digital Twins: Model-Driven and AI Methods – An Introduction – Prof. Giacomo Cappon How Digital Twins Can Enhance Clinical Trials – Prof. Boris Kovatchev Digital Twins, Replay Simulation, and Decision Support – Prof. Anas El Fathi AI Analytics and CGM Data Science – Dr. Clara Mosquera-Lopez This episode is an essential listen...2025-03-2019 min
ATTD: Advanced Technologies and Treatments for DiabetesAdult Obesity: Causes, Risks, and Management Strategies, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Adult Obesity: Causes, Risks, and Management Strategies, featuring insights on the SELECT trial, GLP-1 receptor agonists, and innovative approaches to managing obesity, Type 2 diabetes, and metabolic liver diseases. Join us as we summarize key takeaways from these thought-provoking presentations: Lessons from the SELECT Trial: Rethinking the Clinical Applications for the GLP-1RA Semaglutide – Prof. Donna Ryan Heterogeneity of Obesity and Type 2 Diabetes – Prof. Ewan Pearson Incretin-Based Therapies for the Treatment of Obesity-Related Diseases – Prof. Francesco Giorgino Prevalence and Rationale for New Terminologies in NAFLD – Dr. Samita Garg 2025-03-2031 min
ATTD: Advanced Technologies and Treatments for DiabetesBeta Cell Therapies for Type 1 Diabetes, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Beta Cell Therapies for Type 1 Diabetes, featuring innovative discussions on regenerative therapies, stem cell approaches, and novel treatments to protect and regenerate beta cells in the fight against Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Human Beta Cell Regenerative Drug Therapy: A Journey from Impossible to Possible – Dr. Andrew Stewart Optimizing Differentiation and Engraftment of Stem Cell-Derived Islets for Type 1 Diabetes Treatment – Dr. Maria Cristina Nostro Optimizing Stem Cell-Derived Beta Cell Function for Transplantation – Prof. Matthias Hebrok Novel Type 1 Diabetes Therapies T...2025-03-2028 min
ATTD: Advanced Technologies and Treatments for DiabetesEarly Detection: Innovative Technologies for Type 1 Diabetes Diagnosis, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into Early Detection: Innovative Technologies for Type 1 Diabetes Diagnosis, featuring groundbreaking discussions on population-level screening, antibody detection, and strategies to implement early detection of Type 1 diabetes globally. Join us as we summarize key takeaways from these thought-provoking presentations: General Population Screening – Successes and Pitfalls – Dr. Anastasia Albanese-O’Neill Update on ADIR (Antibody Detection Israeli Research) Project – Prof. Moshe Phillip & Dr. Tal Oron Screening of Type 1 Diabetes and Celiac Disease of the General Pediatric Population in Italy: Progress and Preliminary Results – Prof. Emanuele Bosi EDENT1FI: Toward General Population Scre...2025-03-2020 min
ATTD: Advanced Technologies and Treatments for DiabetesCGM as a Potential Diagnostic Tool, ATTD 2025 Conference Catch-UpIn this episode of ATTD 2025 Conference Catch-Up, we dive into CGM as a Potential Diagnostic Tool, featuring insights on the evolving role of Continuous Glucose Monitoring (CGM) in diagnosing and managing both Type 1 and Type 2 diabetes, with a focus on early detection and precision medicine. Join us as we summarize key takeaways from these thought-provoking presentations: Precision Medicine in Stage 2 Type 1 Diabetes – Prof. Chantal Mathieu Data-Driven Approaches in Endocrinology: From CGM to Omics Data – Dr. Smadar Shilo Consensus on the Use of CGM in Individuals with Type 2 Diabetes – Prof. Tadej Battelino This episode is...2025-03-2018 min
ATTD: Advanced Technologies and Treatments for DiabetesElevating Early Careers in Diabetes, ATTD 2025 Conference Catch-UpIn this episode of ATTD Conference Catch-Up, we dive into Elevating Early Careers: Insights, Skills, and Strategies, featuring expert insights on career development, mentorship, and effective communication for early-career professionals in diabetes and endocrinology.Join us as we summarize key takeaways from these thought-provoking presentations:Career Planning, Goal-Setting, and Networking Strategies – Prof. Olga KordonouriInsights into Manuscript Writing – Dr. Steven KahnSkills for Presenting Research to Diverse Audiences – Prof. Partha KarThis episode is an essential listen for early-career researchers, clinicians, and healthcare professionals in diabetes, looking to refine their career strategies, improve research writing, and enhance presen...2025-03-1921 min
ATTD: Advanced Technologies and Treatments for DiabetesHot Topics Preview for ATTD 2025 - The ATTD Conference Catch-UpIn this episode of ATTD Conference Catch-Up, we dive into the hot topics planned for discussion at ATTD 2025. Get ready for an exciting preview of the latest advancements and cutting-edge research that will shape the future of diabetes care. From innovative technologies and treatments to breakthroughs in clinical practices, we’ll cover key sessions and discussions you won't want to miss. Whether you're attending or unable to make it, this episode ensures you stay at the forefront of diabetes innovation. Tune in for impactful insights and a glimpse of what's to come at this year’s pr...2025-03-1823 min
ATTD: Advanced Technologies and Treatments for DiabetesYour Introduction to the ATTD Conference Catch-upWe’re excited to launch ATTD Conference Catch-Up - a brand-new, AI-powered podcast designed for healthcare professionals who want to stay ahead in diabetes research, technology and treatments.Whether you’re attending ATTD 2025 in Amsterdam or following from afar, this podcast ensures you don’t miss a thing. Using AI-driven podcast generation, we’ll bring you key takeaways from select sessions, breaking down the latest in diabetes technology, CGM advancements, beta cell therapies, AI applications, and more. Get ready for insightful summaries!ATTD 2025 is taking place on March 19-22, 2025, in Amsterdam, the Neth...2025-03-1701 min
Candid Conversations with Charles Hsuan from Flying Kite#76 Candid conversations: Leander Opperman | Why not all teeth are created equal in strategyEver heard the word "strategy" and thought, "What's that all about?" It's a fancy term, but let's break it down.
Imagine your orthodontist telling you, "You don't HAVE to brush every tooth, but if you only brush the ones you want to keep, that's pretty smart." That's strategy! It's about choosing to do what really matters.
Now, lots of companies come up with plans, but not all of them follow through. That's where Leander Opperman of Unlok Consulting steps in. He helps law firms and their young leaders make and stick to their plans. With...2024-04-1933 min
The Art of Selling Online CoursesUnderstanding Your Audience with AI - with Lisa CattoSend us a textWelcome to another episode of The Art Of Selling Online Courses. In this episode, I have the pleasure of interviewing Lisa Catto, an experienced business owner and thought leader in business growth and digital marketing. Together, we delve into the world of selling online courses and explore the strategies that can take your e-learning business to the next level.We'll uncover the secrets to keeping your students engaged throughout their learning journey and discuss the game-changing potential of AI tools for content creation.We'll also discover how automation c...2023-08-0420 min
Be QueensCreate Your Reality: From Goal-Setting to Action with Jennie LokJennie, or Jennie from the b(LOK) from Brooklyn NYC and now living in the San Francisco Bay Area is looking to #unLOK the potential of her community as a founder of two real estate companies Zen Coast Homes & Zen Coast University.
2023-05-2946 min
Nuh podcastcara unlok mac menggunakan apple watch. #mac #macos #Macbook #Applehalo guys, gimana puasanya? semoga lancar ya. di tutorial ini, aku akan menjelaskan, gimana caranya unlok mac dengan apple watch. mau tahu lengkapnya? cus simak sampai selesai ya.2023-03-3103 min
Conversaciones en DiabetesNovedades de Congreso ATTD 2023 - Tecnología y Diabetes. Dras Lorena Lequi y Paula Paz PovedanoBienvenidos a un nuevo episodio!! Continuamos con la cuarta temporada de Conversaciones en Diabetes. Hoy vamos a tener un formato distinto y vamos a conversar con 2 colegas expertas sobre las novedades del Congreso “Tecnología avanzada y terapéutica para la diabetes” más conocido como ATTD, que se llevó a cabo en Berlín, a fines de febrero de este año.
Vamos a hablar de todo lo nuevo en tecnología aplicada para el tratamiento diabetes, con datos super interesantes sobre infusores de insulina, monitoreo continuo, sistemas integrados, aplicaciones y mucho más… así como sobre otros asp...2023-03-2043 min
Unlock Yourself: coaching e formazione per la crescita professionale e organizzativa!36. In che modo parlate dei fallimenti in azienda?? 🙄☠️I problemi, gli obiettivi non raggiunti o anche i fallimenti di alcuni progetti, possono essere trattati in modi molto diversi nelle aziende. Uno dei tratti culturali più distintivi di un'organizzazione è proprio come gestisce al suo interno il rapporto con i problemi. Ci sono infatti alcune organizzazioni che nascondono i problemi sotto il tappeto, altre che li vedono come un tabù, altre ancora che ne fanno quasi una medaglia da ostentare. Ma qual è il modo migliore per gestire i problemi in azienda? Scoprilo in questa puntata del #podcast Unlok Yourself ! Scopri altri contenuti audio, video e articoli visitando il nostro sito: www...2021-11-0518 min
Unlock Yourself: coaching, formazione e HR management per la crescita professionale e organizzativa!36. In che modo parlate dei fallimenti in azienda?? 🙄☠️I problemi, gli obiettivi non raggiunti o anche i fallimenti di alcuni progetti, possono essere trattati in modi molto diversi nelle aziende.
Uno dei tratti culturali più distintivi di un'organizzazione è proprio come gestisce al suo interno il rapporto con i problemi.
Ci sono infatti alcune organizzazioni che nascondono i problemi sotto il tappeto, altre che li vedono come un tabù, altre ancora che ne fanno quasi una medaglia da ostentare.
Ma qual è il modo migliore per gestire i problemi in azienda?
Scoprilo in questa puntata del #podcast Unlok Yourself !
Scop...2021-11-0518 min
Unlock Yourself: coaching, formazione e HR management per la crescita professionale e organizzativa!34. Le caratteristiche di una cattiva LeadershipQuali sono le caratteristiche di una cattiva leadership? 😰 👎
La leadership negativa nelle organizzazioni ha degli effetti devastanti sulla motivazione delle persone e se diffusa può portare ad una morte lenta di un'organizzazione.
Ma quali sono le caratteristiche dei peggiori leader?
Scoprilo in questa puntata del #podcast Unlok Yourself
#BadLeadership #Coaching #HrInnovation2021-08-2711 min
Changing Lives Selling KnivesJennie Lok - UnLOK Your PotentialJennie Lok is a successful real estate professional and investment coach. She bought her first home at age 23, and has since built a portfolio of 70 rentals across 4 states. After graduating from the University of Southern California, she got a sales position with Oracle. But her passion for real estate has led her to a career role with Keller-Williams, and her success with investment rentals has opened the door for her to coach others through Zen Coast University. Jennie’s aspiration is to help others to unLOK their potential for financial freedom and fulfillment in life. To get ac...2021-04-1448 min
P.O.E.T RADIO STATIONUNLOK YOUR MIND (60's vs 2000's) Ep. 915 - P.O.E.T RADIO STATION2021-02-0450 min
Decoding Success with Matt LeBrisUnLOKing Your Potential with Dan LokARE YOU READY TO UNLOK YOUR GREATEST POTENTIAL? We are so thrilled to bring to you our friend, Dan Lok. Dan jumped on Decoding Success to let us know what power (and he could only choose one) would his Iron Man suit have if he had access to it, his biggest takeaways from martial arts, how he views the current state of entrepreneurship, and more. Be on the lookout for Dan's new book, Unlock It. And, a huge shout out to our partners, GenM and Audible. Check out GenM here: https://genm.grsm.io/DecodingSuccess Check out Audible here: audibletrial...2019-09-051h 05
CRUSHING IT IN REAL ESTATE8. UnLok Your Potential with Jennie Lok, 2019 30 under 30 Realtor!This week, we have Jennie Lok on Crushing it in Real Estate! Jennie is a 2019 30 under 30 Realtor in the San Francisco Bay Area, who made the list in her first attempt! (That's an amazing accomplishment). She's also a rental property investor in the Bay Area and she also has many properties out of state. Join us this week as we dive into Jennie's world and unLOK our potential with her expertise.
---
This episode is sponsored by
· Anchor: The easiest way to make a podcast. https://anchor.fm/app
Support this podcast: https://anchor.fm/crushingitinrealestate/support2019-08-1835 min